A new machine learning technique can predict the dynamics between microbes and therapeutics with unprecedented accuracy.
Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.
Deep data analytics drive the development of a technique
that sheds light on drug action by monitoring the dynamics of thousands of protein complexes simultaneously
within intact cells
modified zebrafish are promising in the detection of harmful compounds for screening drug candidates
molecules promise to relieve debilitating eye disease
Toxic peptide payload can be delivered exclusively to cancer cells